Business Assignment


Being a student of Science, it becomes boring to make an assignment in Business. However, according to the rules of faculty; I had to complete an assignment. The  assignment have published here, thus anyone can take idea about how to create an business assignment.

Objectives of the Study

The main objective of the study is to prepare a business plan for Pharmaceuticals Limited. In brief the other objectives can be stated as follows:
·         To acquire knowledge how to prepare a business plan.
·         To obtain knowledge about pharmaceuticals business.
·         To gather knowledge about the structure of pharmaceuticals business.
·         To know the manufacturing process of pharmaceuticals.
·         To get the overall idea about the marketing strategy of pharmaceuticals company.
·         To know about the flow of inventory of pharmaceuticals company.



Methodology of the Report

The report is descriptive in nature. To fulfill the objectives of this report total methodology has divided into two major parts:

a)      Data Collection Procedure:
In order to make the report more meaningful and presentable, two sources of data and information have been used widely.

                                                                      
Both primary and secondary data sources were used to generate the report.

The “Primary Sources” are as follows:-
  • Visited some leading pharmaceutical companies of Bangladesh like – Beximco Pharmaceuticals Ltd., ACI Limited, Drug International etc. and observed their work procedures
  • Took some opinion from the executives of these companies.
The “secondary Sources” are as follows:-
  • Annual report of Beximco Pharmaceuticals Ltd., ACI Limited, Drug International etc.
  • Office files and documents.
  • Study related books, articles and journals.
  • Web sites.

b)     Data Processing & Analysis:
Collected information have then processed & compiled with the aid of MS Word, Excel & other related computer software. Necessary tables have been prepared on the basis of collected data and various statistical techniques have been applied to analyses on the basis of classified information

Limitations of the Study

To prepare a report on the topic like this in a short duration is not easy task. In preparing this report some problems and limitations have encountered which are as follows:

a)      The main constraint of the study was insufficiency of information, which was required for the study.
b)     As the data, in most cases, are not in organized way, Beximco Pharmaceuticals Ltd., ACI Limited, Drug International etc. failed to provide all information.
c)      Due to time limitation, many of the aspects could not be discussed in the present report.
d)     Lack of opportunity to access to internal data.
e)      I had to base on secondary data for preparing this report.
f)       Lack of cooperation of the executives.
g)      Lack of experience.


Part 2: Business Description and Management Segment

General Discussion about the Pharmaceuticals Business

Bangladesh is a country whose population is increasing at an alarming rate. But, the people of Bangladesh are not so much educated and they are not conscious about their health. For this reason, they are affected by various diseases. Besides this Bangladesh is frequently affected by various natural calamity which also spread out various diseases. So, medicine is very essential for the people of Bangladesh and it is one of the basic needs of people. Along with this, pharmaceutical products can also be exported in abroad which will bring huge foreign currency in our country and help in development of the economy of the country. From that perspective, pharmaceutical business can be attributed as a major source of investment for many entrepreneurs. The potentiality of this sector is very high. Huge demand can be created if a sustainable investment, management and marketing policy is formulated and implemented accordingly.


About COMET Pharmaceuticals Limited

COMET will symbolizes a name – a state of mind. But its journey to the growth and prosperity will not be a bed of roses. From the inception, it has to run a long way to be pioneer in this sector. This business entity will be set up under the Companies Act-1994 as a public limited company. Since it will be a public limited company, it will require at least seven promoters to set up the company. Then it has to obtain Certificate of Commencement to start its business operation. Then it will be registered in the stock exchanges of the country. It will publish the prospectus to invite general public to apply in the Initial Public Offer (IPO). After getting the paid up capital the company will start its business and will try to achieve its goal.

Vision, Mission and Objectives of COMET Pharmaceuticals Limited

Vision:
We view business as a means to the materials and social well beings of the investors, employees and the society at large, leading to accretion of wealth through financial and moral gains as a part of the process of the human civilization.

Mission:
Our mission is to produce and provide quality & innovative healthcare relief for people, maintain stringently ethical standard in business operation also ensuring benefit to the shareholders, stakeholders and society at large.
Objectives:
Our objective is to conduct transparent business operation based on market mechanism within the legal and social framework with aims to attain the mission reflected by our vision.


Management Structure

Top Management: Board of Directors
As per provisions of the Article of Association, Board of Directors holds periodic meetings to resolve issue of policies and strategies, recording minutes/decisions for implementation by the Executive Management.

Executive Management:
The Executive Management will be headed by the Managing Director, the Chief Executive Officer (CEO) who will be delegated necessary and adequate authority by the Board of Directors. The Executive Management will operate through further delegations of authority at every echelon of the line management. The Executive management will be responsible for preparation of segment plan/sub-segment plans for every profit centers with budgetary target for every item of goods & services and held accountable for deficiencies with appreciation for exceptional performance. These operations will be carried out by the executive management through series of committees, sub-committees, ad-hoc committees, standing committees assisting the line management.

Standing Committees:
  1. Internal Audit Committee,
  2. ISO Audit Committee,
  3. Social/Environmental Audit Committee, and
  4. Performance/Evaluation Audit Committee.

Employment Relation Committee:
  1. Remuneration Committee,
  2. Work Environment Committee, and
  3. Employees Welfare & Recreation Committee.

Management Committee:

  1. Product Planning and Development Committee,
  2. Quality Control and Research Committee,
  3. Production and Inventory Management Committee,
  4. Market Research Committee,
  5. Export Promotion Committee,
  6. Agency/Distribution Management Committee.


























Segment Report:
The company’s chief operating decision makers will review the profit and loss of the company on an aggregate basis and manage the operation of the company as a single operating segment. Accordingly, the company will operate in one segment, which is the business of developing, manufacturing and marketing of drugs for health care for all lives in species.

Risk perception:
Company management will perceive investment risks within the national and international economic situation in relation to legal requirements involving intellectual property rights, scientific invention, World Trade Organization (WTO) regulation and monetary fiscal investment policies and has prepared its production & marketing strategy to meet the challenges from these risks.


3.7       Profile of COMET Pharmaceuticals Limited


                                                 I.      Establishment of the Company: 2011

                                              II.      Capital Structure

Capital Structure
Shareholders Equity:
taka
Share Capital
432000000
Share Premium
2035465000
General Reserve
105878200
Tax Holiday Reserve
1208110872
Retained Earnings
2390465078
Total
6171919150
Long Term Loan - Secured
389193080
Minority Interest
29766940




                                           III.      Board of Directors

1.          Chairman
2.          Director
3.          Managing Director
4.          Director

মন্তব্যসমূহ